PMAM
SAGE

Picton Mahoney Asset Management’s Sage Therapeutics SAGE Stock Holding History

Picton Mahoney Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,423
Closed -$35K – 1015
2024
Q4 		$35K Buy
6,423
+3,581
+126% +$21.9K ﹤0.01% 419
2024
Q3 		$21K Buy
+2,842
New +$26K ﹤0.01% 464
2020
Q1 		– Sell
-4,920
Closed -$355K – 339
2019
Q4 		$355K Sell
4,920
-14,436
-75% -$1.78M 0.02% 196
2019
Q3 		$2.72M Buy
19,356
+2,370
+14% +$396K 0.19% 103
2019
Q2 		$3.11M Sell
16,986
-119
-0.7% -$20.3K 0.21% 95
2019
Q1 		$2.72M Buy
+17,105
New +$2.48M 0.21% 96
2018
Q1 		– Sell
-16,200
Closed -$2.67M – 223
2017
Q4 		$2.67M Sell
16,200
-69,900
-81% -$6.78M 0.19% 106
2017
Q3 		$5.36M Sell
86,100
-9,655
-10% -$758K 0.4% 82
2017
Q2 		$7.63M Sell
95,755
-27,300
-22% -$1.97M 0.54% 72
2017
Q1 		$8.74M Buy
123,055
+10,400
+9% +$609K 0.59% 64
2016
Q4 		$5.75M Buy
112,655
+77,255
+218% +$3.64M 0.47% 78
2016
Q3 		$1.63M Sell
35,400
-16,600
-32% -$676K 0.11% 144
2016
Q2 		$1.57M Sell
52,000
-1,300
-2% -$43.3K 0.1% 152
2016
Q1 		$1.71M Sell
53,300
-3,800
-7% -$134K 0.11% 147
2015
Q4 		$3.33M Sell
57,100
-19,800
-26% -$981K 0.2% 112
2015
Q3 		$3.25M Buy
76,900
+39,400
+105% +$2.43M 0.19% 113
2015
Q2 		$2.74M Buy
+37,500
New +$2.41M 0.14% 123

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Picton Mahoney Asset Management's SAGE Position: Q1 2025 in Review

Picton Mahoney Asset Management sold out of Sage Therapeutics (SAGE) in Q1 2025, closing a stake of 6,423 shares — an estimated $35K sold.

Picton Mahoney Asset Management first reported a position in SAGE in Q2 2015 and held it in 17 quarters. The position peaked at $8.74M in Q1 2017. 198 funds tracked by Wall St. Rank hold SAGE as of Q1 2025.

  • Picton Mahoney Asset Management reported no remaining Sage Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 6,423 Sage Therapeutics shares in Q1 2025, an estimated $35K.
  • Picton Mahoney Asset Management first reported a position in Sage Therapeutics in Q2 2015 and held it in 17 quarters.
  • Picton Mahoney Asset Management's Sage Therapeutics position peaked at $8.74M in Q1 2017.
  • 198 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2025, filed 7 May 2025.